Evaxion Biotech A/S (NASDAQ:EVAX) Q4 2024 Earnings Call Transcript April 1, 2025
Evaxion Biotech A/S misses on earnings expectations. Reported EPS is $-0.07 EPS, expectations were $-0.03.
Operator: Good day, and thank you for standing by. Welcome to the Evaxion Biotech Business Update Full Year 2024 Conference Call and Webcast. At this time, all participants will be in listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions]...
